Latest news Back to 'Institute of Cancer and Genomic Sciences' Research paves way for rapid non-invasive diagnosis of some childhood brain tumours DescriptionA study led by the University of Birmingham has found combining advanced imaging and artificial intelligence techniques can accurately classify the characteristics of common types of childhood brain tumours.Date:19/02/2021 Birmingham Brief: What happened to cancer while COVID-19 took the front seat? DescriptionProfessor Pam Kearns, Director of the Institute of Cancer and Genomic Sciences, writes an opinion piece on how COVID-19 has replaced cancer as 'the big C'.Date:29/01/2021 Better post-surgical care would boost cancer survival chances DescriptionPatients' chances of survival after cancer surgery is strongly linked with the standard of post-operation hospital care, a major international study suggests.Date:25/01/2021 Research reveals mental health impact of COVID-19 on hospital healthcare workers DescriptionA study, published in BJPsych Open found that around a third of hospital healthcare workers reported clinically significant symptoms of anxiety and depression following the initial COVID-19 pandemic peak in the UK.Date:18/01/2021 Cancer research reveals how different mutations in one gene can cause different types of disease DescriptionLeading cancer experts at the University of Birmingham have solved a long-standing question of how various types of mutations in just one gene cause different types of disease.Date:15/01/2021 Study finds paediatric cancer patients at no greater risk of severe COVID-19 infection DescriptionResults from the first national study of children with cancer who test positive from COVID-19 has found that these patients do not appear to be at any increased risk of severe COVID-19 infection.Date:14/01/2021 New COVID-19 test gives positive result in just a few minutes DescriptionA new COVID-19 test that reduces testing time from 30 minutes to less than five and delivers accurate results has been developed by researchers at the University of Birmingham.Date:06/01/2021 Cancer Research UK appoints new Trustee from the University of Birmingham DescriptionCancer Research UK has announced the appointment of Professor Pamela Kearns, Director of the University of Birmingham's Institute of Cancer and Genomic Sciences, as a Trustee and Member.Date:05/01/2021 Large study in UK NHS labs shows gold standard accuracy of Oxford Nanopore's COVID-19 test LamPORE for both symptomatic and asymptomatic patients DescriptionA study of more than 23,000 samples carried out by teams across the UK, including the University of Birmingham, shows Oxford Nanopore's COVID-19 test, LamPORE, is highly accurate for the detection of SARS-CoV-2.Date:21/12/2020 New treatment could spare early-stage rectal cancer patients life-altering side effects DescriptionA new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.Date:11/12/2020 Displaying 1 to 10 of 146 Previous 1 2 3 4 5 … Next